Quest Diagnostics (DGX) Gross Profit (2016 - 2025)
Quest Diagnostics' Gross Profit history spans 17 years, with the latest figure at $910.0 million for Q4 2025.
- For Q4 2025, Gross Profit rose 6.06% year-over-year to $910.0 million; the TTM value through Dec 2025 reached $3.7 billion, up 12.98%, while the annual FY2025 figure was $3.7 billion, 12.98% up from the prior year.
- Gross Profit for Q4 2025 was $910.0 million at Quest Diagnostics, down from $949.0 million in the prior quarter.
- Across five years, Gross Profit topped out at $1.1 billion in Q3 2021 and bottomed at $736.0 million in Q4 2023.
- The 5-year median for Gross Profit is $860.5 million (2024), against an average of $880.2 million.
- The largest annual shift saw Gross Profit skyrocketed 98.19% in 2021 before it decreased 26.12% in 2022.
- A 5-year view of Gross Profit shows it stood at $1.0 billion in 2021, then fell by 26.12% to $758.0 million in 2022, then fell by 2.9% to $736.0 million in 2023, then increased by 16.58% to $858.0 million in 2024, then increased by 6.06% to $910.0 million in 2025.
- Per Business Quant, the three most recent readings for DGX's Gross Profit are $910.0 million (Q4 2025), $949.0 million (Q3 2025), and $943.0 million (Q2 2025).